Vial
CRX Peptide Labs
3 public reports
Retatrutide
Retatrutide is listed for controlled laboratory research. Public-reference molecular information is presented separately from measured results in 3 published third-party reports.
Read the published research →PUBLIC COAS
3
MOL. WT
4,731.4
FORMAT
Lyophilized
SEQUENCE
39 aa
DATA
Lab report
CATALOG
RT10 / RT20
Quantity per vial
PRICE · CAD
$89.99
1
View COAs3 reports
Tested sample
15 mg
Task number
137040
Analysis date
Apr 29, 2026
Measured results
Retatrutide: 16.53 mg · Purity: 99.829%
Tested sample
30 mg
Task number
171219
Analysis date
Jun 23, 2026
Measured results
Retatrutide: 34.92 mg · Purity: 99.472%
Tested sample
60 mg
Task number
171267
Analysis date
Jun 23, 2026
Measured results
Retatrutide: 64.85 mg · Purity: 99.753%
| Tested sample | Task number | Analysis date | Measured results | Report |
|---|---|---|---|---|
| 15 mg | 137040 | Apr 29, 2026 | Retatrutide: 16.53 mg · Purity: 99.829% | |
| 30 mg | 171219 | Jun 23, 2026 | Retatrutide: 34.92 mg · Purity: 99.472% | |
| 60 mg | 171267 | Jun 23, 2026 | Retatrutide: 64.85 mg · Purity: 99.753% |
◆ Lab report available
◆ Shipping shown at checkout
Research overview
Retatrutide is listed for controlled laboratory research. Public-reference molecular information is presented separately from measured results in 3 published third-party reports.
Published third-party results apply to the named tested samples in each report. Sample strengths and measured values remain report-specific and should not be read as blanket claims for every size or future lot.
Intended use
For laboratory research use only. Not a drug, food, or cosmetic. Not for human or veterinary use, ingestion, or any form of consumption. Sold exclusively to qualified researchers.
What's included
◆One lyophilized vial at the selected quantity
◆Access to the published sample report
◆Order and shipping details shown at checkout
